These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21193016)

  • 1. Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor.
    Cuevas P; Carceller F; Angulo J; González-Corrochano R; Cuevas-Bourdier A; Giménez-Gallego G
    Neurosci Lett; 2011 Mar; 491(1):1-7. PubMed ID: 21193016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of intra-tumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate.
    Cuevas P; Carceller F; Reimers D; Cuevas B; Lozano RM; Giménez-Gallego G
    Neurol Res; 1999 Jul; 21(5):481-7. PubMed ID: 10439429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving strategies: future treatment of glioblastoma.
    Chamberlain M
    Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxy-2,5 benzenesulphonate (dobesilate) elicits growth arrest and apoptosis in glioma cells.
    Cuevas P; Díaz-González D; Giménez-Gallego G; Dujovny M
    Neurol Res; 2005 Dec; 27(8):797-800. PubMed ID: 16354538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate.
    Angulo J; Peiró C; Romacho T; Fernández A; Cuevas B; González-Corrochano R; Giménez-Gallego G; de Tejada IS; Sánchez-Ferrer CF; Cuevas P
    Eur J Pharmacol; 2011 Sep; 667(1-3):153-9. PubMed ID: 21703259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.
    Doblas S; Saunders D; Kshirsagar P; Pye Q; Oblander J; Gordon B; Kosanke S; Floyd RA; Towner RA
    Free Radic Biol Med; 2008 Jan; 44(1):63-72. PubMed ID: 18045548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities.
    Angulo J; Cuevas P; Cuevas B; El Youssef M; Fernández A; Martínez-Salamanca E; González-Corrochano R; Giménez-Gallego G
    J Transl Med; 2015 Feb; 13():48. PubMed ID: 25638171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
    Grobben B; De Deyn PP; Slegers H
    Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response of rosacea to dobesilate.
    Cuevas P; Arrazola JM
    Eur J Med Res; 2005 Oct; 10(10):454-6. PubMed ID: 16287608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
    deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
    Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.